Pharma-Bio Serv, Inc.
PBSV
$0.42
-$0.16-27.16%
OTC PK
| 04/30/2026 | 01/31/2026 | ||||
|---|---|---|---|---|---|
| Revenue | 17.77% | 6.76% | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | 17.77% | 6.76% | |||
| Cost of Revenue | 14.52% | 12.27% | |||
| Gross Profit | 24.86% | -3.54% | |||
| SG&A Expenses | -7.28% | -7.40% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | 7.06% | 4.67% | |||
| Operating Income | 253.12% | 29.11% | |||
| Income Before Tax | 555.89% | 748.84% | |||
| Income Tax Expenses | 77.78% | -18.18% | |||
| Earnings from Continuing Operations | 608.21% | 33,000.00% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | 608.21% | 33,000.00% | |||
| EBIT | 253.12% | 29.11% | |||
| EBITDA | 298.62% | 32.17% | |||
| EPS Basic | 628.57% | -- | |||
| Normalized Basic EPS | 550.00% | 900.00% | |||
| EPS Diluted | 900.00% | -- | |||
| Normalized Diluted EPS | 550.00% | 900.00% | |||
| Average Basic Shares Outstanding | -0.02% | -0.17% | |||
| Average Diluted Shares Outstanding | -0.01% | -0.14% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||